Epibatidine structure–activity relationships

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

Epibatidine is a potent but nonselective nAChR agonist. Its biological effects appear to be mediated largely by alpha4beta2 nAChRs. Surprisingly, only a limited number of epibatidine analogues have been synthesized and evaluated in in vitro assays. Even fewer analogues have received in vivo pharmacological evaluation. In this paper, SAR studies directed toward epibatidine analogues will be reviewed.

Knowledge Graph

Similar Paper

Epibatidine structure–activity relationships
Bioorganic & Medicinal Chemistry Letters 2004.0
Epibatidine isomers and analogues: Structure–activity relationships
Bioorganic & Medicinal Chemistry Letters 2006.0
Epibatidine analogues as selective ligands for the αxβ2-containing subtypes of nicotinic acetylcholine receptors
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 3′-(Substituted Phenyl)epibatidine Analogues. Nicotinic Partial Agonists
Journal of Natural Products 2010.0
Corrigendum to “Epibatidine structure–activity relationships”
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3′-(substituted pyridinyl)-deschloroepibatidine analogs
Bioorganic & Medicinal Chemistry 2015.0
Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2′-Fluoro-3′-(substituted pyridinyl)-7-deschloroepibatidine Analogues
Journal of Medicinal Chemistry 2014.0
Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3′-(substituted phenyl)deschloroepibatidine analogs
Bioorganic & Medicinal Chemistry 2008.0
Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 3‘-Substituted Deschloroepibatidine Analogues. Novel Nicotinic Antagonists
Journal of Medicinal Chemistry 2005.0